NABUMETONE
- Product NDC
- 61919-668
- 11-digit product format
- 619190668
- Labeler code
- 61919
- Product ID
- 61919-668_83872091-eaeb-d369-e053-2991aa0a998e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NABUMETONE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA078671
- Marketing category
- ANDA
- Marketing start
- 2016-12-22
- Marketing end
- 0000-00-00
- Substance
- NABUMETONE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-668-60 | NABUMETONE | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-668 | NABUMETONE TABLET, FILM COATED NABUMETONE TABLET [DIRECT RX] | 2 | Legacy NDC, 1 package rows | 20190312_4445f9d9-4e89-5d88-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-668-30 | 61919066830 | 30 TABLET, FILM COATED in 1 BOTTLE (61919-668-30) | 2019-08-12 | 0000-00-00 | No | No | Current |
| 61919-668-60 | 61919066860 | 60 TABLET, FILM COATED in 1 BOTTLE (61919-668-60) | 2016-12-22 | 0000-00-00 | No | No | Current |
| 61919-668-90 | 61919066890 | 90 TABLET, FILM COATED in 1 BOTTLE (61919-668-90) | 2019-08-12 | 0000-00-00 | No | No | Current |